Milestone Scientific Inc. MLSS
0.29 USD -0.01 (-3.34%)
At closeNov 10, 2026, 4:00 PM EST
0.31 +0.02 +5.14%
After hours · Nov 10, 4:00 PM ET
0.2919 Day range 0.3097
0.22 52-week range 0.58
- YTD
- +8.11%
- 1 year
- -23.18%
News
benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session Gainers Milestone Scientific (AMEX:MLSS) stock moved upwards by 19.5% to $0.36 during Friday's pre-market session. The company's market cap stands at $27.1 million. Eton Pharmaceuticals (NASDAQ:ETON)…
globenewswire.com Milestone Scientific Provides Major Commercial Growth Update as CompuFlo® Expands Across 30 Million+ Annual Global Epidural Procedures Company Reports 500+ U.S. Leads, Expanding Healthcare Network Relationships, Federal Market Access, International Distribution and 300+ Issued and Pending Patents Worldwide
defenseworld.net Critical Survey: TerrAscend (OTCMKTS:TSNDF) versus Milestone Scientific (NYSE:MLSS) TerrAscend (OTCMKTS:TSNDF - Get Free Report) and Milestone Scientific (NYSE: MLSS - Get Free Report) are both small-cap healthcare companies, but which is the superior investment? We will compare the…
benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session Gainers Flyte Aviation, Inc. Common Stock (AMEX:VJET) stock moved upwards by 34.0% to $2.17 during Monday's after-market session. Option Care Health (NASDAQ:OPCH) shares rose 20.92% to $28.26. The…
benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session Gainers NewGenIvf Group (NASDAQ:NIVF) stock moved upwards by 56.7% to $0.16 during Friday's pre-market session. Stablecoin Development (AMEX:SDEV) stock rose 30.86% to $4.79. The company's market cap…
benzinga.com Why Synaptics Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket Synaptics surged 14.5% after amending its $123/share cash buyout by onsemi; AMOD led gainers, while WCT fell 20.3% premarket.
globenewswire.com Milestone Scientific Highlights Building a Scalable Growth Platform for CompuFlo® Medical Business CompuFlo Builds Momentum as Physician Adoption, Reimbursement Access, Commercial Coverage and Clinical Evidence Expand CompuFlo Builds Momentum as Physician Adoption, Reimbursement Access, Commercial…- benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session Gainers Milestone Scientific (AMEX:MLSS) stock moved upwards by 11.8% to $0.44 during Monday's after-market session. The company's market cap stands at $36.9 million. Evotec (NASDAQ:EVO) stock rose…
globenewswire.com Milestone Scientific Announces Pain and Spine Specialists and Dr. Sudhir Rao as CompuFlo® Development Partner and Advisor ROSELAND, N.J., Sept. 16, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American: MLSS), a leading developer of computerized drug delivery and injection technologies, today announced that…
benzinga.com Milestone Scientific Directors Convert $465K Loans Into Equity, Eliminating Debt And Achieving Debt‑Free Balance Sheet Milestone Scientific Inc. (MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that three members of its Board of…- benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session Gainers iTonic Holdings (NASDAQ:ITOC) stock moved upwards by 32.0% to $0.41 during Friday's after-market session. The company's market cap stands at $4.9 million. Quanterix (NASDAQ:QTRX) shares…
seekingalpha.com Milestone Scientific Inc. (MLSS) Q2 2026 Earnings Call Transcript Milestone Scientific Inc. (MLSS) Q2 2026 Earnings Call Transcript
benzinga.com Conference Call:
Milestone Scientific Affirms FY2026 Sales Guidance of $9.800M-$10.200M vs $9.910M Est Milestone Scientific (AMEX:MLSS) affirms FY2026 sales outlook from $9.800 million-$10.200 million to $9.800 million-$10.200 million vs $9.910 million estimate.- benzinga.com Transcript: Milestone Scientific Q2 2026 Earnings Conference Call Milestone Scientific (AMEX:MLSS) released second-quarter financial results and hosted an earnings call on Friday. Read the complete transcript below. Benzinga APIs provide real-time access to…
globenewswire.com Milestone Scientific Reports Financial Results for Second Quarter 2026 Medical Segment Revenue Grows 231% Year-Over-Year Enters Strategic Distribution Agreement to Expand CompuFlo® Access Across VA and Department of Defense Health Systems Reaffirms 2026 Outlook for…
benzinga.com Milestone Scientific Q2 EPS $(0.01), Inline, Sales $2.841M Beat $2.700M Estimate Milestone Scientific (AMEX:MLSS) reported quarterly losses of $(0.01) per share which met the analyst consensus estimate. This is a 50 percent increase over losses of $(0.02) per share from the same…
globenewswire.com Milestone Scientific Schedules Second Quarter 2026 Financial Results Conference Call ROSELAND, N.J., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections,…
globenewswire.com Milestone Scientific Announces Strategic Federal Distribution Partnership with Red One Medical to Expand Commercial Access for the CompuFlo® Epidural System Partnership Expands Commercial Reach Across VA, Department of Defense and Other Federal Healthcare Systems Partnership Expands Commercial Reach Across VA, Department of Defense and Other Federal…
globenewswire.com Milestone Scientific Launches First Phase of AI Strategy with Pilot Debut of Milo, an AI-enabled Digital Engagement Platform, at ASPN 2026 AI-powered Initiative Aims to Enhance Customer Engagement, Accelerate Commercial Execution and Support Long-Term Growth- benzinga.com Milestone Scientific Expects Q2 Revenue Of ~$2.8M, Up 21% YoY; H1 Revenue Of ~$5M, Up 9% YoY Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced preliminary, unaudited revenue for…
globenewswire.com Milestone Scientific Reports Preliminary 1H 2026 Revenue of ~$5.0M, +9% YoY; Q2 2026 Revenue of ~$2.8M, +21% YoY Medical Segment Momentum Accelerates, Posting 300% Growth Versus Q2 2025 Company to Showcase Technology at American Society of Pain & Neuroscience Conference in Miami Beach, July 16–18, Alongside…
globenewswire.com Milestone Scientific Strengthens Board to Support Next Phase of Growth ROSELAND, N.J., June 25, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections,…- benzinga.com Milestone Scientific Notes Growing Clinical Adoption And Physician Acceptance Of Its CompuFlo Epidural System After Research Publication Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments utilizing Dynamic Pressure Sensing™ (DPS) technology, today highlighted the continued growth in…
globenewswire.com Milestone Scientific Highlights Growing Clinical Adoption and Expanding Physician Acceptance of CompuFlo® Across Epidural, Neuromodulation, and Interventional Pain Procedures ROSELAND, N.J., May 27, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American: MLSS), a leading developer of computerized drug delivery instruments utilizing Dynamic Pressure Sensing™…
seekingalpha.com Milestone Scientific Inc. (MLSS) Q1 2026 Earnings Call Transcript Milestone Scientific Inc. (MLSS) Q1 2026 Earnings Call Transcript
benzinga.com Full Transcript: Milestone Scientific Q1 2026 Earnings Call 
benzinga.com Reported earlier, Milestone Scientific Affirms FY2026 Sales Guidance of $9.800M-$10.200M vs $9.910M Est Milestone Scientific (AMEX:MLSS) affirms FY2026 sales outlook from $9.800 million-$10.200 million to $9.800 million-$10.200 million vs $9.910 million estimate.
globenewswire.com Milestone Scientific Reports Financial Results for First Quarter 2026 Operating Loss Reduced As Company Advances Toward Profitability Reaffirms Outlook for Double-Digit Revenue Growth in 2026, including Significant Growth in CompuFlo® Sales ROSELAND, N.J., May 14, 2026…- benzinga.com Milestone Scientific Q1 EPS $(0.01), Inline, Sales $2.162M Miss $2.252M Estimate Milestone Scientific (AMEX:MLSS) reported quarterly losses of $(0.01) per share which met the analyst consensus estimate. This is a 50 percent increase over losses of $(0.02) per share from the same…
benzinga.com Earnings Scheduled For May 13, 2026 
globenewswire.com Milestone Scientific Schedules First Quarter 2026 Financial Results and Business Update Conference Call ROSELAND, N.J., May 07, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide objective, pressure-guided…
globenewswire.com Milestone Scientific Expands CompuFlo® Medical Business with Advisor Program and Growing National Clinical Adoption ROSELAND, N. J. , May 07, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments, today provided an update on the expansion of…- benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session
globenewswire.com Milestone Scientific Inc. Completes $2.15 Million Private Placement Financing Strengthens Balance Sheet and Supports Commercial Growth Strategy; Backed by Long-Term Investors Including CEO and Chairman of the Board Financing Strengthens Balance Sheet and Supports…
benzinga.com Why NN Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket NN Inc. (NNBR) rose in pre-market trading after announcing expected sales growth and raising full-year guidance. Other gainers include NICM, AGAE, IMMP, LIMN, CIIT, MLSS, LAES, GBR, and STNE. Losers…
seekingalpha.com Milestone Scientific Inc. (MLSS) Q4 2025 Earnings Call Transcript Milestone Scientific Inc. (MLSS) Q4 2025 Earnings Call Transcript
benzinga.com Milestone Scientific Sees FY2026 Sales $9.800M-$10.200M vs $9.910M Est Milestone Scientific (AMEX:MLSS) sees FY2026 sales of $9.800 million-$10.200 million vs $9.910 million analyst estimate.
globenewswire.com Milestone Scientific Reports Financial Results for Fourth Quarter and Full Year 2025 Q4 2025 Marks Transition from Restructuring to Growth For 2026, Expects Double-Digit Revenue Growth, 400% Increase in CompuFlo Sales, and Continued Progress Toward Profitability ROSELAND, N.J., March…- benzinga.com Milestone Scientific Q4 EPS $(0.02) Misses $(0.01) Estimate, Sales $2.059M Miss $2.309M Estimate Milestone Scientific (AMEX:MLSS) reported quarterly losses of $(0.02) per share which missed the analyst consensus estimate of $(0.01) by 33.33 percent. This is unchanged from the same period last…
- benzinga.com Earnings Scheduled For March 31, 2026
- benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session
- benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session
- benzinga.com Milestone Scientific Introduces CompuFlo Advisor Program Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide objective, pressure-guided precision, today announced the launch of the CompuFlo®…
- benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com Why Vanda Pharmaceuticals Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket - benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session